好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Two-Year Retrospective Analysis Of Rituximab Therapy In Secondary-Progressive Multiple Sclerosis
Multiple Sclerosis
(-)
228
Authors/Disclosures
Christopher Perrone, MD (University of Pennsylvania, Department of Neurology)
PRESENTER
Dr. Perrone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Biljana Beretich, MD (Maine Medical Partners - Neurology) No disclosure on file
Peter N. Riskind, MD, PhD (UMASS Memorial Hlth Ctr/Dept of Neuro) No disclosure on file
Carolina Ionete, MD (UMass Memorial) Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
No disclosure on file